Antibiotic Resistance
Antibiotic resistance occurs when bacteria develop the ability to defeat the drugs designed to kill them. Antibiotic resistance can naturally evolve via natural selection through random mutation, but it could also be engineered by applying an evolutionary stress on a population. Overuse of broad-spectrum antibiotics, such as second- and third-generation cephalosporin, can develop resistance very easily. Bacteria have an ability to neutralize an antibiotic by changing it in a way that makes it harmless others have learned how to pump an antibiotic back outside of the bacteria. Some bacteria can change their outer structure so that the antibiotic cannot attach itself to the bacteria’s body.
- Emergence of Antibiotic Resistance
- Mechanism of Antibiotic Resistance
Related Conference of Antibiotic Resistance
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Antibiotic Resistance Conference Speakers
Recommended Sessions
- Antibiotics Alternative
- Antibiotic Prophylaxis
- Antibiotic Resistance
- Antibiotics
- Antibiotics and Public Health
- Antibiotics: Industrial Scope
- Antimicrobial
- Application of Antibiotics
- Current Challenge and Market
- Drug Discovery
- Entrepreneurs Investment Meet
- Immunology
- Interaction of Antibiotics
- Mechanism : Antibiotics
- Next Generation Approach
- Oncology Antibiotics
- Pediatric Antibiotics
- Types of Antibiotics
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)
